Table of Contents 1 Leukemia Cancer Market Overview 1.1 Product Overview and Scope of Leukemia Cancer 1.2 Classification of Leukemia Cancer by Types 1.2.1 Global Leukemia Cancer Revenue Comparison by Types (2017-2023) 1.2.2 Global Leukemia Cancer Revenue Market Share by Types in 2017 1.2.3 Acute Myeloid Leukaemia (AML) 1.2.4 Chronic Myeloid Leukaemia (CML) 1.2.5 Acute Lymphoblastic Leukaemia (ALL) 1.2.6 Chronic Lymphocytic Leukaemia (CLL) 1.3 Global Leukemia Cancer Market by Application 1.3.1 Global Leukemia Cancer Market Size and Market Share Comparison by Applications (2013-2023) 1.3.2 Chemotherapy 1.3.3 Radiation Therapy 1.3.4 Targeted Therapy 1.3.5 Biological Therapy 1.3.6 Stem Cell Transplant 1.4 Global Leukemia Cancer Market by Regions 1.4.1 Global Leukemia Cancer Market Size (Million USD) Comparison by Regions (2013-2023) 1.4.1 North America (USA, Canada and Mexico) Leukemia Cancer Status and Prospect (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Leukemia Cancer Status and Prospect (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Leukemia Cancer Status and Prospect (2013-2023) 1.4.4 South America (Brazil, Argentina, Colombia) Leukemia Cancer Status and Prospect (2013-2023) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Leukemia Cancer Status and Prospect (2013-2023) 1.5 Global Market Size of Leukemia Cancer (2013-2023) 2 Manufacturers Profiles 2.1 Biogen 2.1.1 Business Overview 2.1.2 Leukemia Cancer Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Biogen Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.2 GSK 2.2.1 Business Overview 2.2.2 Leukemia Cancer Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 GSK Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.3 Novartis 2.3.1 Business Overview 2.3.2 Leukemia Cancer Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Novartis Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.4 Pfizer 2.4.1 Business Overview 2.4.2 Leukemia Cancer Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Pfizer Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.5 Roche 2.5.1 Business Overview 2.5.2 Leukemia Cancer Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Roche Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.6 Takeda Oncology 2.6.1 Business Overview 2.6.2 Leukemia Cancer Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Takeda Oncology Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.7 Teva Pharmaceutical 2.7.1 Business Overview 2.7.2 Leukemia Cancer Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Teva Pharmaceutical Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.8 Celgene 2.8.1 Business Overview 2.8.2 Leukemia Cancer Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Celgene Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.9 Daiichi Sankyo 2.9.1 Business Overview 2.9.2 Leukemia Cancer Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Daiichi Sankyo Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.10 EISAI 2.10.1 Business Overview 2.10.2 Leukemia Cancer Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 EISAI Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.11 Sunesis Pharmaceuticals 2.11.1 Business Overview 2.11.2 Leukemia Cancer Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Sunesis Pharmaceuticals Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.12 Bristol-Myers Squibb 2.12.1 Business Overview 2.12.2 Leukemia Cancer Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Bristol-Myers Squibb Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) 2.13 Spectrum Pharmaceuticals 2.13.1 Business Overview 2.13.2 Leukemia Cancer Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Spectrum Pharmaceuticals Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) 3 Global Leukemia Cancer Market Competition, by Players 3.1 Global Leukemia Cancer Revenue and Share by Players (2013-2018) 3.2 Market Concentration Rate 3.2.1 Top 5 Leukemia Cancer Players Market Share 3.2.2 Top 10 Leukemia Cancer Players Market Share 3.3 Market Competition Trend 4 Global Leukemia Cancer Market Size by Regions 4.1 Global Leukemia Cancer Revenue and Market Share by Regions 4.2 North America Leukemia Cancer Revenue and Growth Rate (2013-2018) 4.3 Europe Leukemia Cancer Revenue and Growth Rate (2013-2018) 4.4 Asia-Pacific Leukemia Cancer Revenue and Growth Rate (2013-2018) 4.5 South America Leukemia Cancer Revenue and Growth Rate (2013-2018) 4.6 Middle East and Africa Leukemia Cancer Revenue and Growth Rate (2013-2018) 5 North America Leukemia Cancer Revenue by Countries 5.1 North America Leukemia Cancer Revenue by Countries (2013-2018) 5.2 USA Leukemia Cancer Revenue and Growth Rate (2013-2018) 5.3 Canada Leukemia Cancer Revenue and Growth Rate (2013-2018) 5.4 Mexico Leukemia Cancer Revenue and Growth Rate (2013-2018) 6 Europe Leukemia Cancer Revenue by Countries 6.1 Europe Leukemia Cancer Revenue by Countries (2013-2018) 6.2 Germany Leukemia Cancer Revenue and Growth Rate (2013-2018) 6.3 UK Leukemia Cancer Revenue and Growth Rate (2013-2018) 6.4 France Leukemia Cancer Revenue and Growth Rate (2013-2018) 6.5 Russia Leukemia Cancer Revenue and Growth Rate (2013-2018) 6.6 Italy Leukemia Cancer Revenue and Growth Rate (2013-2018) 7 Asia-Pacific Leukemia Cancer Revenue by Countries 7.1 Asia-Pacific Leukemia Cancer Revenue by Countries (2013-2018) 7.2 China Leukemia Cancer Revenue and Growth Rate (2013-2018) 7.3 Japan Leukemia Cancer Revenue and Growth Rate (2013-2018) 7.4 Korea Leukemia Cancer Revenue and Growth Rate (2013-2018) 7.5 India Leukemia Cancer Revenue and Growth Rate (2013-2018) 7.6 Southeast Asia Leukemia Cancer Revenue and Growth Rate (2013-2018) 8 South America Leukemia Cancer Revenue by Countries 8.1 South America Leukemia Cancer Revenue by Countries (2013-2018) 8.2 Brazil Leukemia Cancer Revenue and Growth Rate (2013-2018) 8.3 Argentina Leukemia Cancer Revenue and Growth Rate (2013-2018) 8.4 Colombia Leukemia Cancer Revenue and Growth Rate (2013-2018) 9 Middle East and Africa Revenue Leukemia Cancer by Countries 9.1 Middle East and Africa Leukemia Cancer Revenue by Countries (2013-2018) 9.2 Saudi Arabia Leukemia Cancer Revenue and Growth Rate (2013-2018) 9.3 UAE Leukemia Cancer Revenue and Growth Rate (2013-2018) 9.4 Egypt Leukemia Cancer Revenue and Growth Rate (2013-2018) 9.5 Nigeria Leukemia Cancer Revenue and Growth Rate (2013-2018) 9.6 South Africa Leukemia Cancer Revenue and Growth Rate (2013-2018) 10 Global Leukemia Cancer Market Segment by Type 10.1 Global Leukemia Cancer Revenue and Market Share by Type (2013-2018) 10.2 Global Leukemia Cancer Market Forecast by Type (2018-2023) 10.3 Acute Myeloid Leukaemia (AML) Revenue Growth Rate (2013-2023) 10.4 Chronic Myeloid Leukaemia (CML) Revenue Growth Rate (2013-2023) 10.5 Acute Lymphoblastic Leukaemia (ALL) Revenue Growth Rate (2013-2023) 10.6 Chronic Lymphocytic Leukaemia (CLL) Revenue Growth Rate (2013-2023) 11 Global Leukemia Cancer Market Segment by Application 11.1 Global Leukemia Cancer Revenue Market Share by Application (2013-2018) 11.2 Leukemia Cancer Market Forecast by Application (2018-2023) 11.3 Chemotherapy Revenue Growth (2013-2018) 11.4 Radiation Therapy Revenue Growth (2013-2018) 11.5 Targeted Therapy Revenue Growth (2013-2018) 11.6 Biological Therapy Revenue Growth (2013-2018) 11.7 Stem Cell Transplant Revenue Growth (2013-2018) 12 Global Leukemia Cancer Market Size Forecast (2018-2023) 12.1 Global Leukemia Cancer Market Size Forecast (2018-2023) 12.2 Global Leukemia Cancer Market Forecast by Regions (2018-2023) 12.3 North America Leukemia Cancer Revenue Market Forecast (2018-2023) 12.4 Europe Leukemia Cancer Revenue Market Forecast (2018-2023) 12.5 Asia-Pacific Leukemia Cancer Revenue Market Forecast (2018-2023) 12.6 South America Leukemia Cancer Revenue Market Forecast (2018-2023) 12.7 Middle East and Africa Leukemia Cancer Revenue Market Forecast (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Leukemia Cancer Picture Table Product Specifications of Leukemia Cancer Table Global Leukemia Cancer and Revenue (Million USD) Market Split by Product Type Figure Global Leukemia Cancer Revenue Market Share by Types in 2017 Figure Acute Myeloid Leukaemia (AML) Picture Figure Chronic Myeloid Leukaemia (CML) Picture Figure Acute Lymphoblastic Leukaemia (ALL) Picture Figure Chronic Lymphocytic Leukaemia (CLL) Picture Table Global Leukemia Cancer Revenue (Million USD) by Application (2013-2023) Figure Leukemia Cancer Revenue Market Share by Applications in 2017 Figure Chemotherapy Picture Figure Radiation Therapy Picture Figure Targeted Therapy Picture Figure Biological Therapy Picture Figure Stem Cell Transplant Picture Table Global Market Leukemia Cancer Revenue (Million USD) Comparison by Regions 2013-2023 Figure North America Leukemia Cancer Revenue (Million USD) and Growth Rate (2013-2023) Figure Europe Leukemia Cancer Revenue (Million USD) and Growth Rate (2013-2023) Figure Asia-Pacific Leukemia Cancer Revenue (Million USD) and Growth Rate (2013-2023) Figure South America Leukemia Cancer Revenue (Million USD) and Growth Rate (2013-2023) Figure Middle East and Africa Leukemia Cancer Revenue (Million USD) and Growth Rate (2013-2023) Figure Global Leukemia Cancer Revenue (Million USD) and Growth Rate (2013-2023) Table Biogen Basic Information, Manufacturing Base and Competitors Table Biogen Leukemia Cancer Type and Applications Table Biogen Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) Table GSK Basic Information, Manufacturing Base and Competitors Table GSK Leukemia Cancer Type and Applications Table GSK Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis Leukemia Cancer Type and Applications Table Novartis Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Leukemia Cancer Type and Applications Table Pfizer Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Leukemia Cancer Type and Applications Table Roche Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Takeda Oncology Basic Information, Manufacturing Base and Competitors Table Takeda Oncology Leukemia Cancer Type and Applications Table Takeda Oncology Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors Table Teva Pharmaceutical Leukemia Cancer Type and Applications Table Teva Pharmaceutical Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Celgene Basic Information, Manufacturing Base and Competitors Table Celgene Leukemia Cancer Type and Applications Table Celgene Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors Table Daiichi Sankyo Leukemia Cancer Type and Applications Table Daiichi Sankyo Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) Table EISAI Basic Information, Manufacturing Base and Competitors Table EISAI Leukemia Cancer Type and Applications Table EISAI Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Sunesis Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Sunesis Pharmaceuticals Leukemia Cancer Type and Applications Table Sunesis Pharmaceuticals Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Leukemia Cancer Type and Applications Table Bristol-Myers Squibb Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Spectrum Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Spectrum Pharmaceuticals Leukemia Cancer Type and Applications Table Spectrum Pharmaceuticals Leukemia Cancer Revenue, Gross Margin and Market Share (2016-2017) Table Global Leukemia Cancer Revenue (Million USD) by Players (2013-2018) Table Global Leukemia Cancer Revenue Share by Players (2013-2018) Figure Global Leukemia Cancer Revenue Share by Players in 2016 Figure Global Leukemia Cancer Revenue Share by Players in 2017 Figure Global Top 5 Players Leukemia Cancer Revenue Market Share in 2017 Figure Global Top 10 Players Leukemia Cancer Revenue Market Share in 2017 Figure Global Leukemia Cancer Revenue (Million USD) and Growth Rate (%) (2013-2018) Table Global Leukemia Cancer Revenue (Million USD) by Regions (2013-2018) Table Global Leukemia Cancer Revenue Market Share by Regions (2013-2018) Figure Global Leukemia Cancer Revenue Market Share by Regions (2013-2018) Figure Global Leukemia Cancer Revenue Market Share by Regions in 2017 Figure North America Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure Europe Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure Asia-Pacific Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure South America Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure Middle East and Africa Leukemia Cancer Revenue and Growth Rate (2013-2018) Table North America Leukemia Cancer Revenue by Countries (2013-2018) Table North America Leukemia Cancer Revenue Market Share by Countries (2013-2018) Figure North America Leukemia Cancer Revenue Market Share by Countries (2013-2018) Figure North America Leukemia Cancer Revenue Market Share by Countries in 2017 Figure USA Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure Canada Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure Mexico Leukemia Cancer Revenue and Growth Rate (2013-2018) Table Europe Leukemia Cancer Revenue (Million USD) by Countries (2013-2018) Figure Europe Leukemia Cancer Revenue Market Share by Countries (2013-2018) Figure Europe Leukemia Cancer Revenue Market Share by Countries in 2017 Figure Germany Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure UK Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure France Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure Russia Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure Italy Leukemia Cancer Revenue and Growth Rate (2013-2018) Table Asia-Pacific Leukemia Cancer Revenue (Million USD) by Countries (2013-2018) Figure Asia-Pacific Leukemia Cancer Revenue Market Share by Countries (2013-2018) Figure Asia-Pacific Leukemia Cancer Revenue Market Share by Countries in 2017 Figure China Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure Japan Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure Korea Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure India Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure Southeast Asia Leukemia Cancer Revenue and Growth Rate (2013-2018) Table South America Leukemia Cancer Revenue by Countries (2013-2018) Table South America Leukemia Cancer Revenue Market Share by Countries (2013-2018) Figure South America Leukemia Cancer Revenue Market Share by Countries (2013-2018) Figure South America Leukemia Cancer Revenue Market Share by Countries in 2017 Figure Brazil Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure Argentina Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure Colombia Leukemia Cancer Revenue and Growth Rate (2013-2018) Table Middle East and Africa Leukemia Cancer Revenue (Million USD) by Countries (2013-2018) Table Middle East and Africa Leukemia Cancer Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Leukemia Cancer Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Leukemia Cancer Revenue Market Share by Countries in 2017 Figure Saudi Arabia Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure UAE Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure Egypt Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure Nigeria Leukemia Cancer Revenue and Growth Rate (2013-2018) Figure South Africa Leukemia Cancer Revenue and Growth Rate (2013-2018) Table Global Leukemia Cancer Revenue (Million USD) by Type (2013-2018) Table Global Leukemia Cancer Revenue Share by Type (2013-2018) Figure Global Leukemia Cancer Revenue Share by Type (2013-2018) Figure Global Leukemia Cancer Revenue Share by Type in 2017 Table Global Leukemia Cancer Revenue Forecast by Type (2018-2023) Figure Global Leukemia Cancer Market Share Forecast by Type (2018-2023) Figure Global Acute Myeloid Leukaemia (AML) Revenue Growth Rate (2013-2018) Figure Global Chronic Myeloid Leukaemia (CML) Revenue Growth Rate (2013-2018) Figure Global Acute Lymphoblastic Leukaemia (ALL) Revenue Growth Rate (2013-2018) Figure Global Chronic Lymphocytic Leukaemia (CLL) Revenue Growth Rate (2013-2018) Table Global Leukemia Cancer Revenue by Application (2013-2018) Table Global Leukemia Cancer Revenue Share by Application (2013-2018) Figure Global Leukemia Cancer Revenue Share by Application (2013-2018) Figure Global Leukemia Cancer Revenue Share by Application in 2017 Table Global Leukemia Cancer Revenue Forecast by Application (2018-2023) Figure Global Leukemia Cancer Market Share Forecast by Application (2018-2023) Figure Global Chemotherapy Revenue Growth Rate (2013-2018) Figure Global Radiation Therapy Revenue Growth Rate (2013-2018) Figure Global Targeted Therapy Revenue Growth Rate (2013-2018) Figure Global Biological Therapy Revenue Growth Rate (2013-2018) Figure Global Stem Cell Transplant Revenue Growth Rate (2013-2018) Figure Global Leukemia Cancer Revenue (Million USD) and Growth Rate Forecast (2018 -2023) Table Global Leukemia Cancer Revenue (Million USD) Forecast by Regions (2018-2023) Figure Global Leukemia Cancer Revenue Market Share Forecast by Regions (2018-2023) Figure North America Leukemia Cancer Revenue Market Forecast (2018-2023) Figure Europe Leukemia Cancer Revenue Market Forecast (2018-2023) Figure Asia-Pacific Leukemia Cancer Revenue Market Forecast (2018-2023) Figure South America Leukemia Cancer Revenue Market Forecast (2018-2023) Figure Middle East and Africa Leukemia Cancer Revenue Market Forecast (2018-2023)

Biogen GSK Novartis Pfizer Roche Takeda Oncology Teva Pharmaceutical Celgene Daiichi Sankyo EISAI Sunesis Pharmaceuticals Bristol-Myers Squibb Spectrum Pharmaceuticals